Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187733 · ClinicalTrials.gov registry record
Influence of OCTN2 Variants on Carnitine Status and Plasma Triglycerides
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 16
- Enrollment target
NCT00187733 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 16 participants.
The verdict
NCT00187733 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The current study is part of a large multi-investigator grant to look at the pharmacogenetics of a number of membrane transporters. Previously, the investigators have recruited a cohort of healthy volunteers (Studies of Pharmacogenetics in Ethnically-Diverse Populations, or SOPHIE) and have resequenced the coding region of a number of membrane transporter genes to identify genetic polymorphisms in these genes. Subjects in this cohort have agreed to be called back for recruitment in further studies based on their own genetic sequence, allowing the investigators the possibility to prospectively study the influence of genetic polymorphisms on particular phenotypes (i.e., genotype-to-phenotype studies). The investigators plan to take a genotype-to-phenotype approach to study the influence of specific polymorphisms in the novel organic cation transporter 2 (OCTN2) gene on carnitine and lipid metabolism in healthy subjects.
Interventions
- OTHER Fasting blood and urine collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2005-01 |
| Est. Completion | 2008-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00187733
The ClinicalTrials.gov registry entry for NCT00187733 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fasting blood and urine collection is the first listed.
NCT00187733 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00187733 about?
NCT00187733 is a clinical study titled "Influence of OCTN2 Variants on Carnitine Status and Plasma Triglycerides". The current study is part of a large multi-investigator grant to look at the pharmacogenetics of a number of membrane transporters. Previously, the investigators have recruited a cohort of healthy volunteers (Studies of Pharmacogenetics in Ethnically-Diverse Populations, or SOPHIE) and have resequen...
What is the current status of trial NCT00187733?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2005-01. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00187733?
The interventions under investigation include: Fasting blood and urine collection (OTHER).
Who is sponsoring clinical trial NCT00187733?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.